Alternative Data for GoodRx
About GoodRx
GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and a free-to-use website and mobile app that track prescription drug prices in the United States and provide free drug coupons for discounts on medications. GoodRx checks more than 75,000 pharmacies in the United States.
| Price | $2.40 |
| Target Price | Sign up |
| Volume | 3,811,088 |
| Market Cap | $781M |
| Year Range | $1.87 - $5.12 |
| Dividend Yield | 0% |
| PE Ratio | 25.33 |
| Analyst Rating | 50% buy |
| Industry | Digital health |
In the news
GoodRx Holdings, Inc. Q4 2025 Earnings Call SummaryFebruary 26 - Moby.co |
|
 |
GoodRx offers employers a workaround for GLP-1s, high-cost medsFebruary 24 - Techtarget.com |
Emotional Counseling Service Market Report 2026-2035: A $21.21 Billion Industry by 2030 with Cleveland Clinic, Teladoc Health., LifeStance, GoodRx, Thriveworks, Headspace, Lyra Health, MDLive LeadingFebruary 23 - GlobeNewswire |
|
Headwinds in GoodRx’s (GDRX) Drug Prescription Business Draw Cautious View from JefferiesFebruary 6 - Yahoo Entertainment |
|
Reported Earlier, GoodRx Becomes Core Integration Partner For TrumpRx, Providing Pricing Source For Over 30 Pfizer Brand Medications And Expanding Access To Trusted Prescription SavingsFebruary 5 - Benzinga |
|
 |
60 Degrees expands access to Arakoda with GoodRx partnershipFebruary 2 - Thefly.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 196M | 13M | 183M | 1.1M | 36M | 0.080 |
| Q2 '25 | 203M | 33M | 170M | 13M | 50M | 0.090 |
| Q1 '25 | 203M | 13M | 190M | 11M | 48M | 0.090 |
| Q4 '24 | 199M | 12M | 186M | 6.7M | 42M | 0.090 |
| Q3 '24 | 195M | 12M | 184M | 12M | 38M | 0.080 |
Insider Transactions View All
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Teladoc HealthTDOC |
$5.57 5.1% | 45 |
 |
Veeva SystemsVEEV |
$189.69 3% | 60 |
 |
DoximityDOCS |
$24.78 2.8% | 72 |
 |
Lifestance HealthLFST |
$6.73 2.6% | 55 |
 |
AmwellAMWL |
$5.4 2.9% | 36 |
Read more about GoodRx (GDRX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - GoodRx
The Market Cap of GoodRx is $781M.
As of today, GoodRx's PE (Price to Earnings) ratio is 25.33.
Currently, the price of one share of GoodRx stock is $2.40.
The GDRX stock price chart above provides a comprehensive visual representation of GoodRx's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling GoodRx shares. Our platform offers an up-to-date GDRX stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, GoodRx (GDRX) does not offer dividends to its shareholders. Investors interested in GoodRx should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of GoodRx are Teladoc Health, Veeva Systems, Doximity, Lifestance Health, and Amwell.
